Srinivasan Dasarathy

33.2k total citations · 14 hit papers
237 papers, 16.6k citations indexed

About

Srinivasan Dasarathy is a scholar working on Epidemiology, Hepatology and Physiology. According to data from OpenAlex, Srinivasan Dasarathy has authored 237 papers receiving a total of 16.6k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Epidemiology, 89 papers in Hepatology and 78 papers in Physiology. Recurrent topics in Srinivasan Dasarathy's work include Liver Disease Diagnosis and Treatment (109 papers), Liver Disease and Transplantation (65 papers) and Nutrition and Health in Aging (48 papers). Srinivasan Dasarathy is often cited by papers focused on Liver Disease Diagnosis and Treatment (109 papers), Liver Disease and Transplantation (65 papers) and Nutrition and Health in Aging (48 papers). Srinivasan Dasarathy collaborates with scholars based in United States, India and Canada. Srinivasan Dasarathy's co-authors include Arthur J. McCullough, Manuela Merli, Robert S. O’Shea, Brent A. Neuschwander‐Tetri, Arun J. Sanyal, Rohit Loomba, James Tonascia, Kris V. Kowdley, Jaividhya Dasarathy and David E. Kleiner and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Srinivasan Dasarathy

227 papers receiving 16.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

2014 1.7k citations Brent A. Neuschwander‐Tetri, Rohit Loomba et al. profile →
Alcoholic Liver Disease

2009 817 citations Srinivasan Dasarathy, Arthur J. McCullough et al. Hepatology profile →
EASL Clinical Practice Guidelines on nutrition in chronic liver disease

2018 678 citations Srinivasan Dasarathy et al. profile →
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

2021 646 citations Arun J. Sanyal, Brent A. Neuschwander‐Tetri et al. profile →
Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study

2009 508 citations Srinivasan Dasarathy, Jaividhya Dasarathy et al. profile →
Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease

2018 452 citations Kris V. Kowdley, Manal F. Abdelmalek et al. profile →
Sarcopenia from mechanism to diagnosis and treatment in liver disease

2016 422 citations Srinivasan Dasarathy et al. profile →
ESPEN guideline on clinical nutrition in liver disease

2019 412 citations William Bernal, Srinivasan Dasarathy et al. profile →
Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

2021 367 citations Jennifer C. Lai, Puneeta Tandon et al. Hepatology profile →
A multicenter study to define sarcopenia in patients with end‐stage liver disease

2017 363 citations Elizabeth J. Carey, Jennifer C. Lai et al. Liver Transplantation profile →
Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease

2019 270 citations Laura Wilson, Naga Chalasani et al. profile →
Sarcopenia and frailty in decompensated cirrhosis

2021 224 citations Puneeta Tandon, Jennifer C. Lai et al. profile →
Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis

2021 203 citations Srinivasan Dasarathy, Naim Alkhouri et al. profile →
Estimated Burden of Metabolic Dysfunction–Associated Steatotic Liver Disease in US Adults, 2020 to 2050

2025 55 citations Phuc Le, Srinivasan Dasarathy et al. profile →

Peers

Srinivasan Dasarathy

EPIDE

HEPAT

PHYSI

EDM

SURGE

Leon A. Adams Australia

Mark L. Van Natta United States

Quentin M. Anstee United Kingdom

Maurizio Cassader Italy

Giampaolo Bianchi Italy

Rocío López United States

Hendrik Vilstrup Denmark

Stefano Bellentani Italy

Shira Zelber‐Sagi Israel

Stergios A. Pοlyzos Greece

Leon A. Adams Australia

Srinivasan Dasarathy

18.9k ×1.8

EPIDE

9.1k ×1.3

HEPAT

2.4k ×0.4

PHYSI

7.9k ×2.8

EDM

3.1k ×1.1

SURGE

Citations per year, relative to Srinivasan Dasarathy Srinivasan Dasarathy (= 1×) peers Leon A. Adams

Countries citing papers authored by Srinivasan Dasarathy

Since Specialization

Citations

This map shows the geographic impact of Srinivasan Dasarathy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srinivasan Dasarathy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srinivasan Dasarathy more than expected).

Fields of papers citing papers by Srinivasan Dasarathy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Srinivasan Dasarathy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srinivasan Dasarathy. The network helps show where Srinivasan Dasarathy may publish in the future.

Co-authorship network of co-authors of Srinivasan Dasarathy

This figure shows the co-authorship network connecting the top 25 collaborators of Srinivasan Dasarathy. A scholar is included among the top collaborators of Srinivasan Dasarathy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Srinivasan Dasarathy. Srinivasan Dasarathy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krainer, Adrian R., et al.. (2025). New insights into biomarkers and risk stratification to predict hepatocellular cancer. Molecular Medicine. 31(1). 152–152. 1 indexed citations

Minnick, Ann F., et al.. (2025). The impact of integrated care on clinical outcomes in patients with alcohol-associated liver disease: Early outcomes from a multidisciplinary clinic. Hepatology Communications. 9(2). 2 indexed citations

Kim, Michelle Kang, Carol Rouphael, Ji Yoon Yoon, et al.. (2024). Using the Electronic Health Record to Develop a Gastric Cancer Risk Prediction Model. SHILAP Revista de lepidopterología. 3(7). 910–916.

Dodig, Milan, Min Li, Srinivasan Dasarathy, et al.. (2024). Insulin increases type I collagen synthesis in hepatic stellate cells via α5β1 integrin. PubMed. 4(4).

Yang, Xiaochun, Kazufumi Ohshiro, Patricia S. Latham, et al.. (2024). 459 REGULATION OF CEACAM1 IN METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH) AND HCC BY TGF-β SIGNALING. Gastroenterology. 166(5). S–1547. 1 indexed citations

Chalasani, Naga, Eduardo Vilar‐Gómez, Rohit Loomba, et al.. (2024). PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease. Hepatology. 80(5). 1212–1226. 18 indexed citations

Mishra, Saurabh, Nicole Welch, Shashi Shekhar Singh, et al.. (2024). Ammonia transporter RhBG initiates downstream signaling and functional responses by activating NFκB. Proceedings of the National Academy of Sciences. 121(31). e2314760121–e2314760121. 1 indexed citations

Alkhouri, Naim, et al.. (2023). Prevalence of at-risk NASH and its association with metabolic syndrome in US adults with NAFLD, 2017–2018. Hepatology Communications. 7(1). e0019–e0019. 21 indexed citations

Tu, Wanzhu, Samer Gawrieh, Srinivasan Dasarathy, et al.. (2023). Design of a multicenter randomized clinical trial for treatment of Alcohol-Associated Hepatitis. Contemporary Clinical Trials Communications. 32. 101074–101074. 14 indexed citations

10.

Vatsalya, Vatsalya, Wenke Feng, Maiying Kong, et al.. (2023). The Beneficial Effects of Lactobacillus GG Therapy on Liver and Drinking Assessments in Patients with Moderate Alcohol-Associated Hepatitis. The American Journal of Gastroenterology. 118(8). 1457–1460. 40 indexed citations

11.

Wu, Xiaoqin, Xiude Fan, Megan R. McMullen, et al.. (2022). Macrophage‐derived MLKL in alcohol‐associated liver disease: Regulation of phagocytosis. Hepatology. 77(3). 902–919. 30 indexed citations

12.

Fan, Xiude, Zhengwen Liu, Kyle L. Poulsen, et al.. (2021). Alcohol Consumption Is Associated with Poor Prognosis in Obese Patients with COVID-19: A Mendelian Randomization Study Using UK Biobank. Nutrients. 13(5). 1592–1592. 15 indexed citations

13.

Lai, Jennifer C., Puneeta Tandon, William Bernal, et al.. (2021). Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 74(3). 1611–1644. 367 indexed citations breakdown →

14.

Sarmini, Muhammad Talal, et al.. (2020). Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome. BMJ Open Gastroenterology. 7(1). e000352–e000352. 35 indexed citations

15.

Yodoshi, Toshifumi, Kristin Bramlage, Chunyan Liu, et al.. (2019). Vitamin D deficiency: prevalence and association with liver disease severity in pediatric nonalcoholic fatty liver disease. European Journal of Clinical Nutrition. 74(3). 427–435. 17 indexed citations

16.

Chalasani, Naga, Manal F. Abdelmalek, Rohit Loomba, et al.. (2018). Relationship Between Three Commonly Used Non-invasive Fibrosis Biomarkers and Improvement in Fibrosis Stage in Patients With NASH. PubMed Central. 6 indexed citations

17.

McMahan, Rachel H., Silvia Giugliano, Cara E. Porsche, et al.. (2013). Signal Transduction and Cell Function. Hepatology. 58(S1). 459A–471A. 1 indexed citations

18.

Pagadala, Mangesh, Srinivasan Dasarathy, Bijan Eghtesad, & Arthur J. McCullough. (2009). Posttransplant Metabolic Syndrome. Liver Transplantation. 15(12). 1662–1670. 113 indexed citations

19.

Panigrahi, Aswini K., Subrat Kumar Panda, Rakesh Dixit, et al.. (1997). Magnitude of hepatitis C virus infection in India: prevalence in healthy blood donors, acute and chronic liver diseases.. PubMed. 51(3). 167–74. 63 indexed citations

20.

Acharya, Subrat Kumar, Srinivasan Dasarathy, S Sushma, et al.. (1996). Fulminant Hepatitis in A Tropical Population: Clinical Course, Cause, and Early Predictors of Outcome. Hepatology. 23(6). 1448–1455. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact